On the other hand, phosphorylated p62 was barely detectable in tumour and non-tumour regions of HCC patients positive for anti-hepatitis B virus (HBV) antibody (Fig. 8a); the difference between HBV- and HCV-positive patients was statistically significant (P<0.001). This evidence concerns the gene SQSTM1 and neoplasm.